TAOSHENG PHARMA江苏涛生药业 · EST. 2020
Request a Quote
About Manufacturing Products Quality Contact
Home / About & Facility
Company Profile

Built by two established pharma investors, run as one integrated campus

From raw material to finished dosage form, under one roof, on one 62-mu site in Yancheng, Jiangsu.

Jiangsu Taosheng Pharmaceutical factory exterior
Overview

Founded 2020, jointly invested by two pharmaceutical groups

Jiangsu Taosheng Pharmaceutical Co., Ltd. was founded in March 2020 as a joint investment between Hainan Taosheng Pharmaceutical Co., Ltd. and Yancheng Jiyuan Pharmaceutical Co., Ltd., with registered capital of RMB 41.18 million.

The company is licensed across food production and sales, food additives, health food, pharmaceuticals, and traditional Chinese medicine (TCM) extracts — giving it the regulatory footing to move a single raw material from extraction through to finished dosage form under one roof.

  • AddressNo.1, Longgang Town, Yandu District, Yancheng City, Jiangsu Province, China
  • ShareholdersHainan Taosheng Pharmaceutical Co., Ltd.; Yancheng Jiyuan Pharmaceutical Co., Ltd.
  • Licensed scopeFood, food additives, health food, pharmaceuticals, TCM extracts
  • Registered capitalRMB 41,180,000
Facility & Buildout

A 62-mu campus, built in two phases

Phase I is complete and operating; Phase II is planned to extend capacity into oral liquids and microencapsulated/liposomal delivery formats.

Phase I — Operating

43 mu · 25,700 m² built

Nine dedicated buildings plus utility and safety infrastructure, purpose-built for extraction-to-dosage manufacturing.

  • 1#Production Building
  • 2#Solid Preparation Workshop
  • 3#General Warehouse
  • 4#Extraction Workshop
  • 5#Hazardous Waste Warehouse
  • 6#Wastewater Treatment Station
  • 7#Hazardous Materials Warehouse
  • 8#Equipment Room
  • 9#Tank Farm
  • +Gatehouse, fire pump house & reservoir
Phase II — Planned

19 mu · 20,000 m² planned

Expansion adds two new production lines, extending the company's finished-format range for both domestic and export customers.

  • →Oral liquid line — 60,000,000 bottles / year
  • →Microencapsulated / liposomal products — 300 t / year
Campus building rendering with facade material annotations
FIG. 01 — Facade rendering, office & production building
Campus building exterior photo
FIG. 02 — Completed campus, exterior view
Cleanroom corridor interior photo
FIG. 03 — Cleanroom corridor, production building
Next Step

See the workshops that make it happen

View Manufacturing Capability